ATE255594T1 - Hepatitis b inhibitoren - Google Patents
Hepatitis b inhibitorenInfo
- Publication number
- ATE255594T1 ATE255594T1 AT97946476T AT97946476T ATE255594T1 AT E255594 T1 ATE255594 T1 AT E255594T1 AT 97946476 T AT97946476 T AT 97946476T AT 97946476 T AT97946476 T AT 97946476T AT E255594 T1 ATE255594 T1 AT E255594T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- inhibitors
- peptides
- virus
- inhibit
- Prior art date
Links
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3053496P | 1996-10-31 | 1996-10-31 | |
| PCT/US1997/019965 WO1998018818A2 (en) | 1996-10-31 | 1997-10-31 | Hepatitis b inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE255594T1 true ATE255594T1 (de) | 2003-12-15 |
Family
ID=21854673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97946476T ATE255594T1 (de) | 1996-10-31 | 1997-10-31 | Hepatitis b inhibitoren |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6544520B1 (de) |
| EP (1) | EP0952982B1 (de) |
| JP (2) | JP4091663B2 (de) |
| AT (1) | ATE255594T1 (de) |
| AU (1) | AU5163598A (de) |
| CA (1) | CA2270401A1 (de) |
| DE (1) | DE69726602T2 (de) |
| DK (1) | DK0952982T3 (de) |
| ES (1) | ES2207753T3 (de) |
| PT (1) | PT952982E (de) |
| WO (1) | WO1998018818A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL348766A1 (en) | 1998-12-04 | 2002-06-03 | Biogen | Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| KR100746991B1 (ko) | 2004-08-06 | 2007-08-08 | 한국과학기술연구원 | Ｈｂｖ 코아 단백질과 표면 단백질 간 상호작용의 측정을이용한 ｈｂｖ의 증식 억제물질의 검색방법 |
| KR100949310B1 (ko) * | 2007-11-21 | 2010-03-23 | 한국과학기술연구원 | 세포 영상 기법을 이용한 ｈｂｖ 캡시드 단백질과 표면단백질 간 상호작용 측정 방법과 이를 이용한 ｈｂｖ 증식억제물질의 검색방법 |
| CN101503461B (zh) * | 2009-02-12 | 2011-09-07 | 北京大学人民医院 | 一种具有诱导肝癌细胞凋亡功能的多肽 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204096A (en) | 1984-03-07 | 1993-04-20 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| US5296572A (en) | 1986-04-30 | 1994-03-22 | James Sparrow | Large pore polyamide resin and method of preparation thereof |
| CA1338800C (en) | 1986-06-17 | 1996-12-17 | Michael Houghton | Hepatitis delta and diagnostics and vaccines |
| JPH02273700A (ja) | 1989-04-14 | 1990-11-08 | Olympus Optical Co Ltd | ペプチド |
| US5547669A (en) | 1989-11-03 | 1996-08-20 | Immulogic Pharma Corp | Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I |
| KR940000755B1 (ko) | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
| US5556744A (en) | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
| US5531990A (en) | 1993-12-15 | 1996-07-02 | Health Research, Inc. | Method of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigen |
| US5856459A (en) | 1995-06-06 | 1999-01-05 | Hybridon, Inc. | Oligonucleotides specific for hepatitis B virus |
-
1997
- 1997-10-31 WO PCT/US1997/019965 patent/WO1998018818A2/en active IP Right Grant
- 1997-10-31 DE DE69726602T patent/DE69726602T2/de not_active Expired - Lifetime
- 1997-10-31 PT PT97946476T patent/PT952982E/pt unknown
- 1997-10-31 AU AU51635/98A patent/AU5163598A/en not_active Abandoned
- 1997-10-31 DK DK97946476T patent/DK0952982T3/da active
- 1997-10-31 EP EP97946476A patent/EP0952982B1/de not_active Expired - Lifetime
- 1997-10-31 CA CA002270401A patent/CA2270401A1/en not_active Abandoned
- 1997-10-31 ES ES97946476T patent/ES2207753T3/es not_active Expired - Lifetime
- 1997-10-31 AT AT97946476T patent/ATE255594T1/de active
- 1997-10-31 JP JP52081298A patent/JP4091663B2/ja not_active Expired - Lifetime
-
1999
- 1999-04-29 US US09/302,087 patent/US6544520B1/en not_active Expired - Lifetime
-
2007
- 2007-11-20 JP JP2007300663A patent/JP2008120814A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP4091663B2 (ja) | 2008-05-28 |
| ES2207753T3 (es) | 2004-06-01 |
| JP2008120814A (ja) | 2008-05-29 |
| US6544520B1 (en) | 2003-04-08 |
| JP2001503750A (ja) | 2001-03-21 |
| CA2270401A1 (en) | 1998-05-07 |
| WO1998018818A2 (en) | 1998-05-07 |
| EP0952982A2 (de) | 1999-11-03 |
| DE69726602T2 (de) | 2004-09-30 |
| EP0952982B1 (de) | 2003-12-03 |
| AU5163598A (en) | 1998-05-22 |
| DE69726602D1 (en) | 2004-01-15 |
| DK0952982T3 (da) | 2004-03-29 |
| PT952982E (pt) | 2004-03-31 |
| WO1998018818A3 (en) | 1998-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199801031A1 (ru) | Ингибиторы протеинфарнезилтрансферазы | |
| EA199800667A1 (ru) | Новые фенантридины | |
| CY1106156T1 (el) | Νεα χρηση βουδεσονιδης και φορμοτepολης | |
| DE69832293D1 (de) | Zubereitungen zur abgabe von negativ geladenen molekülen | |
| HUP0300246A2 (en) | Delivery system | |
| EE9900481A (et) | Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks | |
| DE69939864D1 (de) | Ppar-gamma modulatoren | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| AR004357A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos. | |
| ID29158A (id) | Monoester probukol untuk pengobatan penyakit kardiovaskular dan peradangan | |
| NO982310L (no) | Protegriner | |
| BR9707819A (pt) | Imunogenos peptidicos | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| DE69533704D1 (de) | Bradykinin-antagonist peptide mit n-substituierten glycinen | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| DE69938935D1 (de) | Zyklische conotoxin-peptide | |
| EA200000196A1 (ru) | Универсальная плазма крови | |
| EA200000519A1 (ru) | 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| DE69616074D1 (de) | Ara-c derivate | |
| ATE235915T1 (de) | Behandlung von hämorrhagischem virusfieber mit protein c | |
| EA200001164A1 (ru) | КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА | |
| ATE255594T1 (de) | Hepatitis b inhibitoren | |
| NO981019L (no) | Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer | |
| MX9602718A (es) | Hidrofluoroalcanos como solventes de limpieza y desengrasado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0952982 Country of ref document: EP |